Drugs giant GSK is set to move its global headquarters back to central London, ending more than two decades at its Brentford base. Around 3,000 employees will work from The Earnshaw building on ...

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...

U.K. drugmaker GSK on Wednesday cut its vaccine sales guidance for the year after what it called lower-than-expected demand.

GlaxoSmithKline has rejected three Unilever ... The global healthcare company, which has its headquarters in London, has already been preparing to separate its consumer goods division from its ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

Drugmaker GSK backed its yearly guidance, while Aston Martin also maintained its view, a month after the carmaker cut outlook. Here is what you need to know at the London market open: The armed ...

GSK also became the world’s leader in the provision of drugs to treat the three most critical diseases in the developing world: HIV/AIDS, Malaria and Tuberculosis. In addition to merger related ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

the London-based pharma giant announced in an Oct. 21 release. Called the Cambridge-GSK Translational Immunology Collaboration (CG-TIC), the partnership will build on GSK and Cambridge’s ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. The Big Pharma is joining forces with researchers from the Center for Regenerative ...